|

Toripalimab combined with celecoxib Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Sun Yat-sen University1

Indications

  • Watch &Amp; Wait1
  • Celecoxib1
  • Neoadjuvant Immunotherapy1
  • PD-1 Inhibitor1
  • Colorectal Cancer (CRC)1

Other1 trial

Neoadjuvant Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.